Uterine carcinosarcomas: From pathology to practice

Michael D. Toboni, Erin K. Crane, Jubilee Brown, Alexander Shushkevich, Sarah Chiang, Brian M. Slomovitz, Douglas A. Levine, Sean C. Dowdy, Ann Klopp, Matthew A. Powell, Premal H. Thaker

Research output: Contribution to journalReview articlepeer-review

Abstract

Objective: Uterine carcinosarcoma (UCS) is a rare but aggressive cancer. In early-stage disease data guiding treatment is sparse. The purpose of this review is to summarize the findings from the 2019 NRG oncology group summer symposium meeting as well as a review of the current literature, with a particular focus on molecular targets, ongoing clinical trials, and treatment of early and advanced/recurrent disease. Methods: A combination of expert presentations and an extensive literature search was undertaken to summarize the literature in this review. MEDLINE was queried for peer-reviewed publications on UCS. This search was not limited by year or study design, but was limited to English language publications. ClinicalTrials.gov was queried for ongoing trials in UCS. Results: UCS is a rare cancer that is biphasic, with the carcinomatous component driving its aggressive nature. Level 3 evidence regarding early stage disease is lacking, but retrospective data suggests adjuvant therapy is warranted. The recent results of GOG 261 have contributed valuable information towards treatment strategy, including use of paclitaxel and carboplatin for UCS. Clinical trials are ongoing to investigate new targeted agents in UCS. Conclusion: Ongoing endometrial cancer clinical trials now include UCS patients. In combination with advances in molecular profiling, this will provide patients with UCS improved therapeutic options. Until that time, surgical resection and traditional cytotoxic chemotherapy remains standard of care.

Original languageEnglish (US)
Pages (from-to)235-241
Number of pages7
JournalGynecologic oncology
Volume162
Issue number1
DOIs
StatePublished - Jul 2021
Externally publishedYes

Keywords

  • Adjuvant treatment
  • Uterine cancer
  • Uterine carcinosarcoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Uterine carcinosarcomas: From pathology to practice'. Together they form a unique fingerprint.

Cite this